Fingerprint
Dive into the research topics of 'Scaffold hopping of α-rubromycin enables direct access to FDA-approved cromoglicic acid as a SARS-CoV-2 MPro inhibitor'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Scaffold hopping of α-rubromycin enables direct access to FDA-approved cromoglicic acid as a SARS-CoV-2 MPro inhibitor
Hani A. Alhadrami, Ahmed M. Sayed, Heba Al-Khatabi, Nabil A. Alhakamy, Mostafa E. Rateb*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
17
Citations
(Scopus)
16
Downloads
(Pure)